(Q44991015)

8 December 2017

High dose vancomycin for osteomyelitis: continuous vs. intermittent infusion (English)

1 reference

8 December 2017

1 reference

1 reference

A Vuagnat

1

1 reference

8 December 2017

R Stern

2

1 reference

8 December 2017

A Lotthe

3

1 reference

8 December 2017

H Schuhmacher

4

1 reference

8 December 2017

M Duong

5

1 reference

8 December 2017

P Hoffmeyer

6

1 reference

8 December 2017

L Bernard

7

1 reference

8 December 2017

1 August 2004

1 reference

Journal of Clinical Pharmacy and Therapeutics

8 December 2017

1 reference

8 December 2017

29

1 reference

8 December 2017

4

1 reference

8 December 2017

351-357

1 reference

Osteomyelitis: options for diagnosis and management

8 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Vancomycin concentrations in infected and noninfected human bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis: evaluation of efficacy, tolerance and cost

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Continuous versus intermittent infusion of vancomycin in severe Staphylococcal infections: prospective multicenter randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

The VISA/GISA problem: therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Emergence, mechanism, and clinical implications of reduced glycopeptide susceptibility in Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Duration of colonization by methicillin-resistant Staphylococcus aureus after hospital discharge and risk factors for prolonged carriage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

Prevention of central venous catheter associated thrombosis using minidose warfarin in patients with haematological malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2710.2004.00572.X

10.1111/J.1365-2710.2004.00572.X

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference